Psoriasis Epidemiology Forecast 2025-2034

As per the World Psoriasis Day consortium, around 2 to 3% of the population, or 125 million people are affected by psoriasis. Current studies also indicate that over 8 million Americans have psoriasis. Further, it is reported that 30% of psoriasis patients develop psoriatic arthritis.

Psoriasis Epidemiology Forecast Report Coverage

The “Psoriasis Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of psoriasis. It projects the future incidence and prevalence rates of psoriasis across various populations. The study covers age, gender, and type as major determinants of the psoriasis-affected population. The report highlights patterns in the prevalence of psoriasis over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of psoriasis in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Psoriasis Disease Overview

Psoriasis refers to an immune-mediated condition, characterized by thick red patches with silvery scales on the scalp, elbows, and knees. It can cause irritation and itchiness and may even be painful. In severe cases, the disease can affect larger areas of the body. Research indicates that psoriasis could be an autoimmune condition associated with certain autoantigens. Psoriatic patients may experience flare-ups which can triggered by stress or some drugs, alcohol, or weather.

Psoriasis: Treatment Overview

For the treatment of psoriasis, oral or injected medications, topical ointments, and light therapy are commonly used. Topical treatments, including lotions, foams, creams, etc. are prescribed for mild to moderate psoriasis. Oral or injected medications, such as methotrexate, can prove effective for severe psoriasis. It works by suppressing the immune system and slowing cell growth. Other treatment alternatives include biologic response modifiers, immunosuppressants, and oral retinoids, among others.

Epidemiology

The psoriasis epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for psoriasis by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for psoriasis and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• An estimated 125 million individuals (2 to 3% of the total population) worldwide have psoriasis, as per the World Psoriasis Day consortium.
• Plaque psoriasis is reported to account for 80 to 90% of the psoriasis cases. On the other hand, guttate psoriasis develops in 8% of the psoriatic patients.
• Studies show that psoriasis can occur at any age. It often has two peaks of onset, the first reported between 20 to 30 years of age whereas the second occurs between 50 to 60 years of age.
• The heritability of psoriasis is estimated at approximately 60 to 90%, with risk factors including skin trauma, obesity, and smoking, among others.

Country-wise Psoriasis Epidemiology

The psoriasis epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of psoriasis varies between countries owing to differences in factors such as genetic predisposition, lifestyle patterns, access to healthcare, and environmental conditions, among others. As per a 2021 study and 2020 United States census data, psoriasis affects 3.2% of women and 2.8% of men in the United States.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of psoriasis based on several factors.
• Psoriasis Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population and the unmet needs of psoriasis are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of psoriasis epidemiology in the 8 major markets?
• What will be the total number of patients with psoriasis across the 8 major markets during the forecast period?
• What was the country-wise prevalence of psoriasis in the 8 major markets in the historical period?
• Which country will have the highest number of psoriasis patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of psoriasis during the forecast period of 2025-2034?
• What are the currently available treatments for psoriasis?
• What are the disease risks, signs, symptoms, and unmet needs of psoriasis?

This product will be delivered within 3-5 business days.